ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,474Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 34

$1.24M Total Retail Price of All Prescriptions

Rank: 1 out of 34

257 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 257 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 257 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 1,772 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$147 was the average price of a prescription from this provider, compared to $136 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
TRAZODONE HCL 367 38 1 1
SERTRALINE HCL 347 83 2 11
RISPERIDONE 328 51 3 6
BUPROPION XL 324 36 4 8
ZOLPIDEM TARTRATE 319 60 5 3
ESCITALOPRAM OXALATE 317 65 6 18
CITALOPRAM HBR 312 78 7 5
ABILIFY 258 60 8 4
QUETIAPINE FUMARATE 233 45 9 9
LAMOTRIGINE 231 34 10 2
LEVOTHYROXINE SODIUM 222 28 11 17
CYMBALTA 168 28 12 7
GENERLAC 151 115 13 41
LITHIUM CARBONATE 143 0 14 12
BENZTROPINE MESYLATE 134 0 R 15 16
OLANZAPINE 128 39 16 15
DIVALPROEX SODIUM ER 114 0 17 19
CARBAMAZEPINE 112 15 18 47
INVEGA 110 0 19 40
DIVALPROEX SODIUM 108 29 20 20
HYDROCODONE-ACETAMINOPHEN 97 34 S3 21 42
CLOZAPINE 92 14 22 14
SEROQUEL 90 15 23 23
OLANZAPINE ODT 86 17 24 48
OXCARBAZEPINE 86 30 24 35
ROPINIROLE HCL 80 16 26 50
METHYLPHENIDATE HCL 77 27 27 32
HALOPERIDOL 77 0 27 36
VENLAFAXINE HCL ER 72 0 29 10
TOPIRAMATE 70 0 30 34
RANITIDINE HCL 69 0 31 53
OXYBUTYNIN CHLORIDE 68 14 32 54
AMPHETAMINE SALT COMBO 67 13 S2 33 24
TRIHEXYPHENIDYL HCL 66 0 R 34 46
ZIPRASIDONE HCL 65 0 35 26
CLONIDINE HCL 64 0 36 43
BUPROPION HCL SR 64 13 36 21
DONEPEZIL HCL 61 11 38 27
LACTULOSE 57 43 39 57
FANAPT 57 0 39 57
FLUOXETINE HCL 56 0 41 13
POTASSIUM CHLORIDE 55 34 42 62
MIRTAZAPINE 55 23 42 22
HALOPERIDOL DECANOATE 52 0 44 64
LOXAPINE 51 15 45 66
FLUPHENAZINE DECANOATE 50 0 46 68
FUROSEMIDE 50 37 46 68
DOXEPIN HCL 50 0 46 39
PRAZOSIN HCL 50 23 46 31
LISINOPRIL 50 20 46 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.